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BACKGROUND: Smoking cessation is an important strategy for reducing the harmful effects of tobacco, particularly in the prevention of
lung cancer; however, prospective data on the impact of smoking cessation on lung cancer risk in Asian populations are limited.
METHODS: We studied a population-based cohort of Chinese men and women aged 45–74 years – participants of the Singapore
Chinese Health Study. Information on smoking, lifestyle and dietary habits was collected at the time of recruitment in 1993–1998;
and smoking status was assessed again at a second interview in 1999–2004 (mean interval 5.8 years). Participants were followed up
to 31 December 2007, and incident cases of lung cancer were ascertained by linkage with population-wide registries.
RESULTS: Among 45900 participants, there were 463 incident cases of lung cancer. Relative to current smokers, those who quit
smoking subsequent to baseline assessment had a 28% decrease in the risk of lung cancer (adjusted hazard ratio (HR) 0.72; 95% CI
(95% confidence interval): 0.53–0.98). The risk was less than half in ex-smokers who had quit before the first interview and
maintained their status (HR 0.42; 95% CI: 0.32–0.56).
CONCLUSIONS: Reduction in lung cancer incidence with smoking cessation in Asian populations is substantial and can be observed
within a few years after quitting.
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The World Health Organisation recognises tobacco use as the
major preventable cause of adult death from cancer. Approxi-
mately 80% of male and 45% of female lung cancer cases
worldwide are attributable to smoking (Boyle and Levin, 2008).
Evidence from epidemiological studies indicates that within
10 years of quitting smoking, there is a 40–90% reduction in lung
cancer risk, and that the magnitude of risk reduction varies with
the intensity of smoking, time since stopping and age at cessation
(Sobue et al, 2002; Ebbert et al, 2003; Wen et al, 2005; Tverdal and
Bjartveit, 2006; Lam et al, 2007; Gotfredsen et al, 2008; Kenfield
et al, 2008; Song et al, 2008).
Estimates of the benefits of smoking cessation are expected to
be largest in countries where the majority of smokers have
been exposed for a long period of time (International Agency
for Research on Cancer, 2007). This is the case in Western
populations, which are at a more advanced phase of the ‘tobacco
epidemic’ (Huxley et al, 2007). In Asia, where the maximal impact
is yet to be felt, the full magnitude of the effect, and its relation
to time since quitting, has yet to be well documented.
In Singapore, lung cancer remains the most frequent
cancer among men and the third most frequent among women
(Seow et al, 2004). Smoking prevalence stood at 21.8 and 3.5%,
respectively, in 2004 (Ministry of Health, Department of
Epidemiology and Disease Control, 2005); these rates are among
the lowest globally (Jha et al, 2002; Slama, 2008). Active measures
by the government include laws restricting smoking in public
places, prohibition of tobacco advertisements and promotion of
healthy lifestyles (Bhalla et al, 2006). We used data from a
prospective population-based cohort of middle-aged to elderly
Chinese in Singapore to evaluate the effect of cessation on lung
cancer risk, and the potential impact of measures to reduce the
harmful effect of tobacco in Asian populations.
MATERIALS AND METHODS
Study population
The Singapore Chinese Health Study is a prospective cohort
study, and the design and methodology have been described
previously (Hankin et al, 2001). Briefly, the cohort was drawn from
permanent residents or citizens of Singapore who live in
government-built housing estates. Recruitment was restricted only
to men and women of Chinese ethnicity (from the two major
dialect groups, Hokkiens and Cantonese) aged between 45 and 74
years. The population was enrolled between April 1993 and
December 1998, and subsequently re-interviewed in 1999–2004.
Exposure assessment
A face-to-face interview was conducted in the subject’s home at the
time of recruitment by a trained interviewer using a structured
questionnaire, which requested information on demographics,
educational attainment, lifetime use of tobacco, current use of
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family history of cancer. The questionnaire included a validated,
semi-quantitative food frequency section listing 165 food items
commonly consumed in the study population. The second
re-interview, which assessed cigarette smoking as well as other
selected lifestyle factors and medical histories, was conducted from
1999 to 2004, either in-person or over the telephone, using
standardised questionnaire and method.
In both surveys, we obtained information on smoking habits
– participants were asked whether they smoked, average number
of cigarettes smoked per day, age they started smoking regularly
and years since quitting for ex-smokers. Although the style of the
questions differed slightly between the two surveys, all these
variables were included in both questionnaires.
In the baseline questionnaire, subjects were grouped into three
groups according to the answers given to the following question,
‘Have you ever smoked at least 1 cigarette a day for 1 year or
longer?’ Subjects who answered ‘no’ were classified as ‘never
smokers’, those who answered ‘yes, but I quit smoking’ were
classified as ‘former smokers’ and those who answered ‘yes, and
I currently smoke’ were classified as ‘current smokers’. At the
second assessment, the population was again grouped based on the
following two questions, ‘Have you ever smoked more than
100 cigarettes in your lifetime?’ and divided into three groups;
those who answered ‘no’ were classified as ‘never smokers’ and
those who answered ‘yes’ were further classified by a second
question: ‘Have you smoked at least one cigarette in the past
30 days?’ Those answering ‘no’ were classified as ‘former smokers’
and those answering ‘yes’ were classified as ‘current smokers’.
Categories of participants
The grouping criteria were based on the combined answers from
baseline and second survey, and resulted in the following
categories: current smokers, participants stated they were current
smokers at both interviews; new quitters, those who stated they
were smokers at baseline and had quit smoking before the second
interview; continuing ex-smokers, who stated they were former
smokers at both interviews; and never smokers, those who stated
they were never smokers at both interviews.
Case ascertainment
Incident cases of lung cancer occurring between the second interview
and the end of the follow-up period were identified by linkage
with the Singapore Cancer Registry using unique national identi-
fication numbers. A total of 517 incident lung cancer cases were
diagnosed among cohort members between the second interview
and 31 December 2007. The majority (440 or 85.1%) of these were
based on histological diagnoses, 52 (10.1%) cases were diagnosed
clinically, and these were confirmed by manual review of pathology
reports by trained research staff. A total of 25 (4.8%) cases were
identified through death records. The site of origin and histological
subtypes were categorised according to ICD-O (International
Classification of Diseases for Oncology) code. Included in this study
are the following subtypes: adenocarcinoma, squamous cell carci-
noma, small-cell lung cancer and primary lung cancer with other or
unspecified histology.
Data analysis
A total of 63257 subjects were interviewed at baseline. On the
second survey, B17% were not contactable because of death or
physical disability, or could not be reached after three attempts by
mail, phone call or house visit. A total of 52324 subjects were
successfully re-contacted, and the mean period between interviews
was 5.8 years. Any subject with existing cancer diagnosed before
second survey was excluded (n¼2519). Participants who started
smoking after baseline interview (n¼1502) and those whose
responses on both occasions were deemed inconsistent (n¼2403)
were also excluded, leaving a final study population of 45900
subjects, among whom 463 incident cases of lung cancer were
identified.
For each subject, person-years of follow-up were counted from
the date of the second interview to the date of diagnosis of lung
cancer, death or 31 December 2007, whichever occurred first.
Proportional hazards (Cox) regression methods were used to
examine the association between smoking cessation and risk of
lung cancer. We adjusted simultaneously for age at interview
(years), gender, dialect group (Hokkien, Cantonese), body mass
index (BMI), year of recruitment, level of education (no formal
education, primary school, secondary school or above) and daily
intakes of ethanol (grams), fruits, vegetables and juices (grams),
as well as daily dietary intakes of b-cryptoxanthin (mg) and
isothiocyanates (mmol). The proportionality assumption was tested
in the final model and found to be satisfied (P¼0.45). Statistical
computing was conducted using SAS version 9.1 (SAS Institute
Inc., Cary, NC, USA) statistical software package. All P-values
quoted were two sided, and P-values o0.05 were considered
statistically significant.
RESULTS
Among 45900 subjects in this analysis (18688 men and 27212
women), the prevalence rates of current and former smokers were
31.0 and 26.7% among men, and 4.2 and 2.4% for women,
respectively. Ever smokers were older than never smokers. The
results showed that current smokers and recent quitters had lower
BMI at baseline. They were more likely to consume alcohol and
reported lower consumption of vegetables and fruits compared
with continuous ex-smokers and never smokers. Ever smokers
were also less likely than never smokers to have no formal
education (18.5 vs 28.2%) (Table 1). At baseline interview,
continuous ex-smokers also reported the highest intensity of
smoking in the past (32.6% reported 423 cigs/day) compared to
current smokers (19.0%) and new quitters (15.9%) data not shown.
As of 31 December 2007, 463 cases of lung cancer were identified
(314 male and 149 female). There were 177 adenocarcinomas
(38.2%), 74 squamous cell carcinomas (16.0%), 47 small cell
carcinomas (10.2%) and 165 cases (35.6%) which were either of
other histological subtypes (24.4%) or of unknown histology
(11.2%). Compared with current smokers (Table 2), individuals
who quit smoking before the second survey had a 28% decrease in
risk of lung cancer (adjusted hazard ratio (HR) 0.72; 95%
confidence interval (95% CI): 0.53–0.98). Those who quit before
baseline and maintained their status had less than half the risk of
current smokers (HR 0.42; 95% CI: 0.32–0.56). The relative risk of
lung cancer among never smokers was 0.14 (95% CI: 0.11–0.18).
When the analysis was limited to smokers and further adjusted for
smoking intensity and duration at baseline, the estimates were not
materially changed (OR for new quitters 0.75, 95% CI 0.55–1.03;
continuous ex-smokers 0.54, 95% CI 0.39–0.74). When stratified by
gender, the reduction in risk remained strong and statistically
significant among males. The numbers of female smokers and ex-
smokers in this population were too small for a separate analysis to
be meaningful.
DISCUSSION
From the perspective of cancer prevention, our results confirm
that quitting smoking and maintaining that status is associated
with a significant reduction in lung cancer risk in this Asian
population. Importantly, this benefit can be observed within
6 years of quitting. Evidence from this, and other studies is
therefore consistent with the understanding that although some of
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for the higher risk that persists among ex-smokers, cessation
of smoking reduces the period of time for which the bronchial
epithelium is exposed to mutagens, and to the chronic inflamma-
tory state which promotes carcinogenesis (Lee et al, 2009).
Although we did not attempt to verify smoking (and quitting)
status by measuring cotinine levels or through other means, an
important feature of the current study is the use of repeated
measurements and the application of stringent criteria for
classification of smoking status. Smoking behaviour, being dynamic,
may change in an unpredictable manner, and reliance on one
measurement time point may obscure true effects on disease risk.
The short-term (o5 years) benefits of smoking cessation are
arguably more difficult to demonstrate because of the possibility
that individuals may quit because of health problems that may pre-
date a subsequent diagnosis of lung cancer. Earlier studies, both
cohort and case–control, have been inconclusive with respect to
short-term benefits, although the long-term reduction in risk is
clear (International Agency for Research on Cancer, 2007). Such a
bias may indeed be present in this study, and may have led to an
underestimation of the true effect.
Among the limitations of this analysis are that the information
collected as baseline was categorical in nature, and that the actual
changes in the intensity of smoking could not be computed in a
quantitative manner. The relatively short period for ascertainment
of incident cases precluded a more detailed analysis by gender, or
by histological subtype, both of which could yield important and
relevant information.
Although the prevalence of smoking is decreasing in deve-
loped countries, there are worrying observations that in develop-
ing countries such as China (Yang, 1997; Liu et al, 1998) and
India (Reddy et al, 2006), individuals are smoking higher
doses and also starting at an earlier age. Hence, the estimated
lung cancer mortality attributed to smoking in developing Asian
countries can be expected to increase rapidly. Our data
confirm that the beneficial effect of smoking cessation in Asian
populations is likely to be substantial and can be demon-
strated within a relatively short time after quitting. These
findings are relevant for Asian populations at a similar stage
in the tobacco epidemic curve, and underscore the impor-
tance of public health measures not only to prevent initiation
of smoking but also to find effective means of helping current
smokers to quit.
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Table 1 Baseline characteristics of 45900 participants (mean and s.d. or number and %) by smoking category in the Singapore Chinese Health Study
(1993–2007)
Smoking category
Demographics at
baseline recruitment
Total
(n¼45900)
Current smokers
(n¼6955)
New quitters
(n¼1765)
Continuous ex-smokers
(n¼3888)
Never smokers
(n¼33292)
Men 18688 (40.7%) 5802 (83.4%) 1495 (84.7%) 3503 (90.1%) 7888 (23.7%)
Age (years) 55.5 (7.7) 56.2 (7.5) 57.7 (7.6) 59.0 (7.9) 54.9 (7.5)
Body mass index 23.1 (3.3) 22.4 (3.2) 22.9 (3.3) 23.5 (3.4) 23.3 (3.3)
Dialect group, Cantonese 22219 (48.4%) 2714 (39.0%) 719 (40.7%) 1988 (51.1%) 16798 (50.5%)
No formal education 11731 (25.6%) 1467 (21.1%) 340 (19.3%) 523 (13.5%) 9401 (28.2%)
Alcohol intake, g per day 1.6 (7.3) 5.2 (13.5) 3.1 (10.3) 3.0 (10.5) 0.7 (3.6)
Vegetable intake, g per day 112.9 (63.3) 104.4 (61.5) 105.7 (61.7) 114.6 (65.7) 114.9 (63.2)
Fruit intake, g per day 207.0 (168.6) 170.7 (159.7) 186.1 (155.0) 219.8 (172.4) 214.2 (196.6)
Mean time between two interviews, years 5.8 (1.5) 6.0 (1.5) 6.3 (1.5) 5.6 (1.5) 5.7 (1.5)
Table 2 Lung cancer risk by smoking category among 45900 participants in the Singapore Chinese Health Study (1993–2007)
Smoking category
Total Current smokers New quitters Continuous ex-smokers Never smokers
No. at risk (%) 45900 6955 (15.1%) 1765 (3.9%) 3888 (8.5%) 33292 (72.5%)
Person-years of follow-up 290832 41798 10588 23573 214873
Follow-up years, mean (s.d.) 6.3 (1.5) 6.0 (1.7) 6.0 (1.8) 6.1 (1.6) 6.5 (1.4)
Lung cancer risk
All cases
No. of cases (% of total cases) 463 234 (50.5%) 48 (10.4%) 63 (13.6%) 118 (25.5%)
Crude hazard ratio (95% CI) 1.0 (reference) 0.81 (0.59–1.10) 0.48 (0.36–0.63) 0.10 (0.08–0.12)
Adjusted hazard ratio
a (95% CI) 1.0 (reference) 0.72 (0.53–0.98) 0.42 (0.32–0.56) 0.14 (0.11–0.18)
Male only
No. of cases (% in each smoking category) 314 199 (63.4%) 38 (12.1%) 53 (16.9%) 24 (7.6%)
Crude hazard ratio (95% CI) 1.0 (reference) 0.74 (0.52–1.05) 0.44 (0.32–0.59) 0.08 (0.06–0.13)
Adjusted hazard ratio
a (95% CI) 1.0 (reference) 0.64 (0.45–0.91) 0.38 (0.28–0.52) 0.11 (0.07–0.17)
Abbreviations: BMI¼body mass index; CI¼confidence interval.
aMultivariate model adjusted for gender (male, female), dialect group (Cantonese, Hokkien), age at recruitment
(continuous), year at interview (continuous), BMI at baseline (continuous), education (no formal education, primary, secondary and above), ethanol intake (continuous), vegetable
intake (continuous), fruit intake (continuous), dietary intake of b-cryptoxanthin (continuous) and isothiocyanates (continuous).
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